BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 8600065)

  • 21. [Basic molecular biology of colon and rectal carcinoma--when differential diagnosis?].
    Schackert HK; Kruppa C; Hahn M
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():318-22. PubMed ID: 9931632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetics, clinical manifestations and management of FAP and HNPCC.
    Pavlovic-Calic N; Muminhodzic K; Zildzic M; Smajic M; Gegic A; Alibegovic E; Salkic N; Jovanovic P; Basic M; Iljazovic S
    Med Arh; 2007; 61(4):256-9. PubMed ID: 18298004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families.
    Johnson V; Lipton LR; Cummings C; Eftekhar Sadat AT; Izatt L; Hodgson SV; Talbot IC; Thomas HJ; Silver AJ; Tomlinson IP
    J Med Genet; 2005 Oct; 42(10):756-62. PubMed ID: 15788729
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multi-stage model of adenoma development.
    Pinsky PF
    J Theor Biol; 2000 Nov; 207(2):129-43. PubMed ID: 11034825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Non-steroidal anti-inflammatory drugs and colorectal cancer prevention.
    Sangha S; Yao M; Wolfe MM
    Postgrad Med J; 2005 Apr; 81(954):223-7. PubMed ID: 15811884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inherited susceptibility to colorectal cancer.
    Rowley PT
    Annu Rev Med; 2005; 56():539-54. PubMed ID: 15660526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hereditary colorectal cancer syndromes: familial adenomatous polyposis and lynch syndrome.
    Al-Sukhni W; Aronson M; Gallinger S
    Surg Clin North Am; 2008 Aug; 88(4):819-44, vii. PubMed ID: 18672142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical significance of HNPCC, surgical aspects of early recognition].
    Tanyi M; Kanyári Z; Orosz L; Juhász B; Lukács G; Damjanovich L
    Magy Seb; 2004 Oct; 57(5):267-78. PubMed ID: 15907009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations of the PIK3CA gene in hereditary colorectal cancers.
    Miyaki M; Iijima T; Yamaguchi T; Takahashi K; Matsumoto H; Yasutome M; Funata N; Mori T
    Int J Cancer; 2007 Oct; 121(7):1627-30. PubMed ID: 17546593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The genetics of hereditary colon cancer.
    Rustgi AK
    Genes Dev; 2007 Oct; 21(20):2525-38. PubMed ID: 17938238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The value of MUTYH testing in patients with early onset microsatellite stable colorectal cancer referred for hereditary nonpolyposis colon cancer syndrome testing.
    Riegert-Johnson DL; Johnson RA; Rabe KG; Wang L; Thomas B; Baudhuin LM; Thibodeau SN; Boardman LA
    Genet Test; 2007; 11(4):361-5. PubMed ID: 18294051
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening of patients with a positive family history of colorectal cancer.
    Burt RW
    Gastrointest Endosc Clin N Am; 1997 Jan; 7(1):65-79. PubMed ID: 8995113
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of colorectal cancer in high-risk populations: the increasing role for endoscopy and chemoprevention in FAP and HNPCC.
    Lynch PM
    Digestion; 2007; 76(1):68-76. PubMed ID: 17947820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrent deletions at 6q in early age of onset non-HNPCC- and non-FAP-associated intestinal carcinomas. Evidence for a novel cancer susceptibility locus at 6q14-q22.
    Bläker H; Mechtersheimer G; Sutter C; Hertkorn C; Kern MA; Rieker RJ; Penzel R; Schirmacher P; Kloor M
    Genes Chromosomes Cancer; 2008 Feb; 47(2):159-64. PubMed ID: 18008368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Screening modalities in familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer.
    Spigelman AD
    Gastrointest Endosc Clin N Am; 1997 Jan; 7(1):81-6. PubMed ID: 8995114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic testing in hereditary colorectal cancer: indications and procedures.
    Terdiman JP; Conrad PG; Sleisenger MH
    Am J Gastroenterol; 1999 Sep; 94(9):2344-56. PubMed ID: 10483990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical management of adenomatous polyposis in patients with hereditary non-polyposis colorectal cancer and familial adenomatous polyposis].
    Sheng JQ; Li SR; Yang XY; Zhang YH; Su H; Yu DL; Yan W; Geng HG
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(8):526-9. PubMed ID: 16681880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sporadic and hereditary colorectal cancer. Pathogenetically different with different therapeutic indications].
    Weitz J; Knaebel HP; Büchler MW
    Chirurg; 2003 Aug; 74(8):717-25. PubMed ID: 12928792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Heredity and colorectal cancer].
    Civitelli S; Civitelli B; Pacchiarotti MC; Tanzini G
    Minerva Chir; 1995 Mar; 50(3):167-75. PubMed ID: 7659249
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prevention of colorectal cancer in families with hereditary nonpolyposis colorectal cancer].
    Bernstein IT; Bisgaard ML; Myrhøj T
    Ugeskr Laeger; 2003 Jan; 165(3):221-5. PubMed ID: 12555703
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.